Alcoholic Hepatitis (AH) Completed Phase 2 Trials for Rilonacept (DB06372)

Also known as: Alcoholic Hepatitis / Hepatitis alcoholic / Hepatitis, Alcoholic

IndicationStatusPhase
DBCOND0080941 (Alcoholic Hepatitis (AH))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01903798A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic HepatitisTreatment